Leukotrienes are auto-/paracrine factors in the bovine corpus luteum: An in vitro study

Reproduction in Domestic Animals

Volumn 45, Issue 6, 2010, Pages 1089-1097

  Korzekwa, A ^a   Lukasik, K ^a   Skarzynski, D J ^a  

^a INSTITUTE OF ANIMAL REPRODUCTION AND FOOD RESEARCH   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTRIENE B4; LEUKOTRIENE C4; NITRIC OXIDE; PROGESTERONE; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA;

ANIMAL; ARTICLE; CATTLE; CELL CULTURE; CORPUS LUTEUM; ESTRUS CYCLE; FEMALE; METABOLISM; PHYSIOLOGY;

ANIMALS; CATTLE; CELLS, CULTURED; CORPUS LUTEUM; DINOPROST; DINOPROSTONE; ESTROUS CYCLE; FEMALE; LEUKOTRIENE B4; LEUKOTRIENE C4; NITRIC OXIDE; PROGESTERONE;

BOVINAE;

EID: 78149327257     PISSN: 09366768     EISSN: 14390531     Source Type: Journal    
DOI: 10.1111/j.1439-0531.2009.01500.x     Document Type: Article

References (36)

1. Abu JI, Konye JC, 2000: Leukotriens in gynaecology: the hypothetical value of anti-leukotriene therapy in dysmenorrhoea and endometriosis. Hum Reprod Update 6, 200-205.
2. Arosh JA, Banu SK, Chapdelaine P, Madore E, Sirois J, Fortier MA, 2004: Prostaglandin biosynthesis, transport, and signaling in corpus luteum: a basis for autoregulation of luteal function. Endocrinology 145, 2551-2560.
3. Bäck M, 2007: Leukotriene receptors: crucial components in vascular inflammation. Scientific WorldJournal 7, 1422-1439.
4. Blair RM, Saatman R, Liou SS, Fortune JE, Hansel W, 1997: Roles of leukotrienes in bovine corpus luteum regression: an in vivo microdialysis study. Proc Soc Exp Biol Med 216, 72-80.
5. Bray MA, Ford-Hutchinson AW, Smith MJ, 1981: Leukotriene B4: an inflammatory mediator in vivo. Prostaglandins 22, 213-222.
6. Hattori N, Fujiwara H, Maeda M, Yoshioka S, Higuchi T, Mori T, Ohishi N, Minami M, Fujii S, Ueda M, 1998: Human large luteal cells in the menstrual cycle and early pregnancy express leukotriene A4 hydrolase. Mol Hum Reprod 4, 803-810.
7. Izumi T, Yokomizo T, Obinata H, Ogasawara H, Shimizu T, 2002: Leukotriene receptors: classification, gene expression, and signal transduction. J Biochem 132, 1-6.
8. Jaroszewski JJ, Hansel W, 2000: Intraluteal administration of a nitric oxide synthase blocker stimulates progesterone and oxytocin secretion and prolongs the life span of the bovine corpus luteum. Proc Soc Exp Biol Med 224, 50-55.
9. Jaroszewski JJ, Skarzynski DJ, Hansel W, 2003a: Nitric oxide as a local mediator of prostaglandin F2alpha-induced regression in bovine corpus luteum: an in vivo study. Exp Biol Med (Maywood) 228, 1057-1062.
10. Jaroszewski JJ, Skarzynski DJ, Blair RM, Hansel W, 2003b: Influence of nitric oxide on the secretory function of the bovine corpus luteum: dependence on cell composition and cell-to-cell communication. Exp Biol Med (Maywood) 228, 741-748.
11. Jones TR, Rodger IW, 1999: Role of leukotrienes and leukotriene receptor antagonists in asthma. Pulm Pharmacol 12, 107-110.
12. Jung A, 2003: Anti-leukotrienes in allergic diseases in children. Pol Merkur Lekarski 14, 631-633.
13. Korzekwa A, Jaroszewski JJ, Bogacki M, Deptula KM, Maslanka TS, Acosta TJ, Okuda K, Skarzynski DJ, 2004: Effects of prostaglandin F(2alpha) and nitric oxide on the secretory function of bovine luteal cells. J Reprod Dev 50, 411-417.
14. Korzekwa A, Okuda K, Woclawek-Potocka I, Murakami S, Skarzynski DJ, 2006: Nitric oxide induces apoptosis in bovine luteal cells. J Reprod Dev 52, 353-361.
15. 2α on bovine corpus luteum depends on cell composition and contact. Reprod Domest Anim 43, 464-472.
16. Korzekwa A, Murakami S, Wocławek-Potocka I, Bah MM, Okuda K, Skarzynski DJ, 2008b: The influence of tumor necrosis factor alpha (TNF) on the secretory function of bovine corpus luteum: TNF and its receptors expression during the estrous cycle. Reprod Biol 8, 245-262.
17. Lafrance M, Hansel W, 1992: Role of arachidonic acid and its metabolites in the regulation of progesterone and oxytocin release from the bovine corpus luteum. Proc Soc Exp Biol Med 201, 106-113.
18. Lynch K, O'Neill G, Liu Q, Im D, Sawyer N, Metters M, 1999: Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399, 789-793.
19. Matousek M, Mitsube K, Mikuni M, Brännström M, 2001: Inhibition of ovulation in the rat by a leukotriene B(4) receptor antagonist. Mol Hum Reprod 7, 35-42.
20. Milvae RA, Alila HW, Hansel W, 1986: Involvement of lipoxygenase products of arachidonic acid metabolism in bovine luteal function. Biol Reprod 35, 1210-1215.
21. Murphy RC, Gijón MA, 2007: Biosynthesis and metabolism of leukotrienes. Biochem J 405, 379-395.
22. Niswender GD, Juengel JL, Silva PJ, Rollyson MK, McIntush EW, 2000: Mechanisms controlling the function and life span of the corpus luteum. Physiol Rev 80, 1-29.
23. Okuda K, Korzekwa A, Shibaya M, Murakami S, Nishimura R, Tsubouchi M, Woclawek-Potocka I, Skarzynski DJ, 2004: Progesterone is a suppressor of apoptosis in bovine luteal cells. Biol Reprod 71, 2065-2071.
24. Peters-Golden M, Brock TG, 2000: Intracellular compartmentalization of leukotriene biosynthesis. Am J Respir Crit Care Med 161, 36-40.
25. Rekawiecki R, Kowalik MK, Slonina D, Kotwica J, 2008: Regulation of progesterone synthesis and action in bovine corpus luteum. J Physiol Pharmacol 59, 75-89.
26. Samuelsson B, 2000: The discovery of the leukotrienes. Am J Respir Crit Care Med 161, 2-6.
27. Skarzynski DJ, Okuda K, 1999: Sensitivity of bovine corpora lutea to prostaglandin F2alpha is dependent on progesterone, oxytocin, and prostaglandins. Biol Reprod 60, 1292-1298.
28. Skarzynski DJ, Okuda K, 2000: Different actions of noradrenaline and nitric oxide on the output of prostaglandins and progesterone in cultured bovine luteal cells. Prostaglandins Other Lipid Mediat 60, 35-47.
29. 2α-induced luteolysis in cattle. Biol Reprod 68, 1674-1681.
30. Skarzynski DJ, Bah MM, Wocławek-Potocka I, Deptula K, Korzekwa A, Shibaya M, Pilawski W, Okuda K, 2003b: Roles of tumor necrosis factor-α in the regulation of the estrous cycle in cattle: an in vivo study. Biol Reprod 69, 1907-1913.
31. Skarzynski DJ, Siemieniuch M, Pilawski W, Woclawek-Potocka I, Bah MM, Majewska M, Jaroszewski JJ, 2009: In vitro assessment of progesterone and prostaglandin E2 production by the corpus luteum in cattle following pharmacological synchronization of the estrus. J Reprod Dev 55, 170-176.
32. Taniguchi H, Yokomizo Y, Okuda K, 2002: Fas/Fas ligand system mediates luteal cell death in bovine corpus luteum. Biol Reprod 66, 754-759.
33. Weems YS, Kim L, Humphreys V, Tsuda V, Blankfein R, Wong A, Weems CW, 2007: Effect of luteinizing hormone (LH), pregnancy-specific protein B (PSPB), or arachidonic acid (AA) on secretion of progesterone and prostaglandins (PG) E (PGE; PGE(1) and PGE(2)) and F(2alpha) (PGF(2alpha)) by ovine corpora lutea of the estrous cycle or pregnancy in vitro. Prostaglandins Other Lipid Mediat 84, 163-173.
34. Wittwer J, Hersberger M, 2007: The two faces of the 15-lipoxygenase in atherosclerosis. Prostaglandins Leukot Essent Fatty Acids 77, 67-77.
35. Yoshimura Y, Nakamura Y, Ichikawa F, Oda T, Jinno M, Ando M, Koyama N, Shiokawa S, 1992: Possible involvement of leukotrienes in human luteal function. Acta Endocrinol (Copenh) 127, 246-251.
36. Zipser RD, Laffi L, 1985: Prostaglandins, thromboxanes and leukotrienes in clinical medicine. West J Med 143, 485-497.